News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Alexander C. Okwonna, PharmD

Articles by Alexander C. Okwonna, PharmD

Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"

ByAlexander C. Okwonna, PharmD,Sujit S. Sansgiry, PhD

March 1st 2005

Latest Updated Articles

$Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"$
Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"
Published: March 1st 2005 | Updated:

Trending on AJMC

Team-Based Precision Oncology: Advancing Value and Access in Cancer Care

Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.